74
Views
11
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia – Cancer and leukemia group B study 10107

, , , , , , , & show all
Pages 1274-1278 | Received 01 Jan 2008, Accepted 07 Mar 2008, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Alessandro Morotti, Cristina Panuzzo, Carmen Fava & Giuseppe Saglio. (2014) Kinase-inhibitor–insensitive cancer stem cells in chronic myeloid leukemia. Expert Opinion on Biological Therapy 14:3, pages 287-299.
Read now
Chris Protzel & Oliver W Hakenberg. (2009) Emerging apoptosis agonists for bladder cancer. Expert Opinion on Emerging Drugs 14:4, pages 607-618.
Read now
Douglas W Leaman. (2008) Recent progress in oligonucleotide therapeutics: antisense to aptamers. Expert Opinion on Drug Discovery 3:9, pages 997-1009.
Read now

Articles from other publishers (8)

Mei Lan Tan, Shahrul Bariyah Sahul Hamid, Muhammad Asyraf Abduraman & Heng Kean Tan. 2020. Cancer Immunology. Cancer Immunology 307 353 .
Huanling Wu, L. Jeffrey Medeiros & Ken H. Young. (2018) Apoptosis signaling and BCL-2 pathways provide opportunities for novel targeted therapeutic strategies in hematologic malignances. Blood Reviews 32:1, pages 8-28.
Crossref
Pedro Barata, Anil K. Sood & David S. Hong. (2016) RNA-targeted therapeutics in cancer clinical trials: Current status and future directions. Cancer Treatment Reviews 50, pages 35-47.
Crossref
Mei Lan Tan, Heng Kean Tan & Tengku Sifzizul Tengku Muhammad. 2015. Cancer Immunology. Cancer Immunology 209 242 .
Radoslaw Chaber, Lucja Fiszer-Maliszewska, Dorota Noworolska-Sauren, Justyna Kwasnicka, Grazyna Wrobel & Alicja Chybicka. (2013) The BCL-2 Protein in Precursor B Acute Lymphoblastic Leukemia in Children. Journal of Pediatric Hematology/Oncology 35:3, pages 180-187.
Crossref
Guy Makin & Caroline Dive. 2011. New Agents for the Treatment of Acute Lymphoblastic Leukemia. New Agents for the Treatment of Acute Lymphoblastic Leukemia 117 141 .
Mei Lan Tan, Jer Ping Ooi, Nawfal Ismail, Ahmed Ismail Hassan Moad & Tengku Sifzizul Tengku Muhammad. (2009) Programmed Cell Death Pathways and Current Antitumor Targets. Pharmaceutical Research 26:7, pages 1547-1560.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:4, pages 253-260.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.